Tom Kindlon

Medscape:
“Low-dose naltrexone (LDN) failed to outperform placebo in reducing pain or improving secondary outcomes in women with fibromyalgia”
https://www.medscape.com/viewarticle/low-dose-naltrexone-fails-outperform-placebo-pain-2026a1000iy0

#Fibromyalgia #Fibro #LDN

Low-Dose Naltrexone Fails to Outperform Placebo for Pain in Fibromyalgia Treatment Trial

Low-dose naltrexone does not provide real clinical benefit for patients with fibromyalgia compared to placebo, according to a clinical trial.

Medscape
Jun 12 at 10:22pmWeb